Redmile Group portfolio
61 tracked investments, 14 on the map, $5.4B raised across the mapped portfolio.
- ImmunomePost-IPO Equity
- ZentalisSeries C
- Scholar RockPost-IPO Equity
- Invivyd
- Krystal BiotechPost-IPO Equity
- Absci
- Stoke Therapeutics
- The Oncology Institute of Hope and InnovationPost-IPO Equity
- Hansa BiopharmaPost-IPO Equity
- CeribellSeries C
- GenalyteVenture
- Lycia TherapeuticsSeries C
- ADARx Pharmaceuticals
- Company dissolved
Also in the portfolio
- Ambrosia Biosciences
- Bambusa Therapeutics
- Beauty Health Company
- Quantum SI
- AgomAb Therapeutics
- aTyr Pharma
- Verve Therapeutics
- Atara Biotherapeutics
- Clear Labs
- Impulse Dynamics
- Repare Therapeutics
- Amazon One Medical
- Augmedix
- Evox Therapeutics
- Neuron23
- Replimune Group
- Beam Therapeutics
- Mammoth Biosciences
- ArcherDX
- Deciphera Pharmaceuticals
- Mnemo Therapeutics
- EmployerDirect Healthcare
- GRO Biosciences
- Nurix Therapeutics
- Aurinia Pharmaceuticals
- CorVent Medical
- Pliant Therapeutics
- Sphere Bio
- Shattuck Labs
- Invitae
- AC Immune
- Ayala Pharmaceuticals
- Atreca
- Scancell
- Escient Pharmaceuticals
- IGM Biosciences
- Vapotherm
- Jounce Therapeutics
- Attenua
- Bellicum Pharmaceuticals
- Hookipa Pharma
- MedAvail
- Atea Pharmaceuticals
- Foundation Medicine
- Thriveworks
- Nightstar Therapeutics